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SUMMARY
Introduction. The purpose of this experiment was to study the influence of
apitherapy in acrylamide-induced liver disease in rats. The experimental study objectives
were the evaluation of liver enzyme parameters (ALT, TGO, AP, GGT), in conditions of
chronic liver damage induced by acrylamide. To reduce the factors that accelerate the
progress of liver damage we have administered Apitherapy products.
Materials and methods. Materials: Apitherapy products Apiregya, ApiImunomod,
ApiImunostim. The Apitherapy products were purchased from "Stupina LLC. The animals
were handled under thiopental induced general anesthesia. Determining the level of
investigated parameters, i.e. serum total protein was measured using an automatic analyzer
(Aeroset, Abbott) and commercial kits (Abbott, USA).  A total of 40 Wistar white rats were
used in the study; they were divided evenly into four groups: standard diet control group
(group I), apitherapy and royal jelly control group (group II), acrylamide group (group III),
acrylamide-apitherapy- royal jelly control group (group IV). The animals were kept under
standard light and temperature conditions with access to food and water ad libitum.  The toxic
liver disease in rats was experimentally induced by gastric gavage administration of
acrylamide (in aqueous solution, 50 mg /kg body weight).
Results and discussions. Administration of apitherapy and royal jelly (RJ) products
in experimental animals with acrylamide–induced hepatopathy (Group IV) produced a
reduction towards normal limits of liver enzymes compared to the other studied groups, as
follows: i). compared to the control group with standard diet (Group I), for  ALT (93.85 
2.26 vs. 110.66  10.52); AST (64.78  1.47 vs. 57.94  9.1), alkaline phosphatase (112.42 
4.99 vs. 86.44  6.93), GGT (0.571  0.07 vs. 0.233  0.11); ii) compared to the group
treated with apitherapy and RJ (Group IV), for: ALT (55.28  1.49 vs. 110.66  10.52); AST
(35.35  0.71 vs. 57.96  9.1), alkaline phosphatase (97.28  1.38 vs. 86.44  6.93), GGT
(0.457  0.05 vs. 0.233  0.11). The administration of the apitherapy + RJ to the group which
received the first the acrylamide (group IV) was effective for maintaining the TGO values
within close limits to the standard food group values (group II); bringing within the absolute
normal limits for TGP value and bringing within limits comparable with the values of group
II, which received the apitherapy and royal jelly.
Conclusions. It is recommended to administer the Apitherapy preparations Apiregya,
ApiImunostim, ApiImunomod, for normalizing the liver enzymes in liver damage induced by
toxic food.
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